Ankara Bilkent City Hospital is a full-service city hospital located in Ankara, Turkey. Opened in 2019, it is the biggest in the country having a total of 3,704 hospital beds.
There are 3,704 beds in Ankara City Hospital.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Ankara City Hospital Bilkent
57
Hoffmann-La Roche
17
Janssen Research & Development, LLC
11
Eli Lilly and Company
5
Turkish League Against Rheumatism
3
Ankara Yildirim Beyazıt University
2
Pfizer
2
Sinovac Research and Development Co., Ltd.
2
Akdeniz University
1
Arch Biopartners Inc.
1
Arcus Biosciences, Inc.
1
Clinical Trials at Ankara City Hospital
During the past decade, Ankara City Hospital conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 4 clinical trials were completed, i.e. on
average, 3.4% percent of trials that started reached the finish line to date. In the past 5 years, 99 clinical trials started and 3 clinical trials were completed. i.e. 3%
of trials that started reached the finish line.
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
2019-06-10
2023-04-01
Active, not recruiting
543
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ankara City Hospital" #1 sponsor was "Ankara City Hospital Bilkent" with 57 trials, followed by "Hoffmann-La Roche" with 17 trials
sponsored, "Janssen Research & Development, LLC" with 11 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Turkish League Against Rheumatism"
with 5 trials sponsored. Other sponsors include 21 different institutions and
companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara City Hospital"
#1 collaborator was "Ankara City Hospital Bilkent" with 2 trials as a collaborator, "Klinar CRO" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Düzen Laboratories Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Ankara City Hospital
According to Clinical.Site data, the most researched conditions in "Ankara City Hospital" are
"Carcinoma, Non-Small-Cell Lung" (6 trials), "Covid19" (6 trials), "Postoperative Pain" (5 trials), "Cardiac Surgery" (4 trials) and "Arthritis, Psoriatic" (3 trials). Many other conditions were trialed in "Ankara City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Ankara City Hospital
Most popular intervention types in "Ankara City Hospital" are "Drug" (46 trials), "Other" (32 trials), "Procedure" (19 trials), "Device" (10 trials) and "Diagnostic Test" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Atezolizumab" (7 trials), "Carboplatin" (7 trials), "Paclitaxel" (5 trials) and "Pemetrexed" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Ankara City Hospital
The vast majority of trials in "Ankara City Hospital" are
98 trials for "All" genders, 14 trials for "Female" genders and 7 trials for "Male" genders.
Clinical Trials Status at Ankara City Hospital
Currently, there are 59 active trials in "Ankara City Hospital".
6 are not yet recruiting,
36 are recruiting,
14 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 44 completed trials in Ankara City Hospital,
1 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Ankara City Hospital, 4 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 29 trials that are defined as “Not Applicable".